These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)]. Lemmer B. Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492 [Abstract] [Full Text] [Related]
3. Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice. Elonen E. Med Biol; 1975 Aug; 53(4):231-7. PubMed ID: 241887 [Abstract] [Full Text] [Related]
4. [Pharmacology of acebutolol in animals]. Basil B. Nouv Presse Med; 1975 Dec 31; 4(46 Suppl):3217-21. PubMed ID: 1219628 [Abstract] [Full Text] [Related]
5. Propranolol in the treatment of angina: a review. Prichard BN. Postgrad Med J; 1976 Dec 31; 52 Suppl 4():35-41. PubMed ID: 787954 [Abstract] [Full Text] [Related]
10. A comparative study of the activity of beta-adrenoceptor antagonists in man. Taylor SH, Thadani U, Davidson C, singleton W, Myint S. Int J Clin Pharmacol Biopharm; 1975 Jul 31; 12(1-2):305-6. PubMed ID: 240783 [Abstract] [Full Text] [Related]
11. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity]. Marmo E, Rossi F, Lampa E, Chieppa S, Apolito A, Del Vecchio F. Arch Sci Med (Torino); 1978 Jul 31; 135(1):57-78. PubMed ID: 25058 [Abstract] [Full Text] [Related]
13. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol. Bodem G, Brammell HL, Weil JV, Chidsey CA. J Clin Invest; 1973 Apr 31; 52(4):747-54. PubMed ID: 4144332 [Abstract] [Full Text] [Related]
15. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. Antonaccio MJ, High J, DeForrest JM, Sybertz E. J Pharmacol Exp Ther; 1986 Jul 31; 238(1):378-87. PubMed ID: 2873238 [Abstract] [Full Text] [Related]
16. Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient. Shand DG. Circulation; 1983 Jun 31; 67(6 Pt 2):I2-5. PubMed ID: 6133642 [Abstract] [Full Text] [Related]
17. A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings]. Harry JD, Knapp MF, Linden RJ, Newcombe CP, Stoker JB. Br J Clin Pharmacol; 1975 Aug 31; 2(4):374P. PubMed ID: 9951 [No Abstract] [Full Text] [Related]
18. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Man in't Veld AJ, Schalekamp MA. Postgrad Med J; 1983 Aug 31; 59 Suppl 3(689):140-58. PubMed ID: 6139800 [Abstract] [Full Text] [Related]
19. Effect of some beta-adrenoceptor blockers and of (+) propranolol on adrenaline-induced pulmonary edema in mice. Jayachandran C, Prakash N. Indian J Physiol Pharmacol; 1983 Aug 31; 27(1):50-2. PubMed ID: 6133833 [Abstract] [Full Text] [Related]
20. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs. Bilski A, Wale J, Dawes PM. Br J Pharmacol; 1976 Mar 31; 56(3):362P. PubMed ID: 4182 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]